Business Description
HeraMED Ltd
ISIN : AU0000028367
Description
HeraMED Ltd is engaged in developing, connected pregnancy monitoring solutions for home and professional use. It has developed a foetal heartbeat monitor called HeraBEAT which is a medical-grade, clinically-validated, smart and connected Ultrasound Foetal Doppler device predominantly for use by an expectant mother to self-monitor her foetus' heart rate (FHR). It is also focused on the commercialization and deployment of its HeraCARE pregnancy monitoring solution. Geographically, the company generates a majority of its revenue from the United States of America followed by Australia and Israel.
Financial Strength
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 3.46 | |||||
Equity-to-Asset | 0.23 | |||||
Debt-to-Equity | 0.45 | |||||
Debt-to-EBITDA | -0.05 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | -24.05 | |||||
Beneish M-Score | -3.96 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 11.7 | |||||
3-Year EPS without NRI Growth Rate | 10.6 | |||||
3-Year FCF Growth Rate | 10.2 | |||||
3-Year Book Growth Rate | -51 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 83.91 | |||||
9-Day RSI | 72.44 | |||||
14-Day RSI | 64.25 | |||||
12-1 Month Momentum % | -74.25 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.28 | |||||
Quick Ratio | 1.04 | |||||
Cash Ratio | 0.7 | |||||
Days Inventory | 487.68 | |||||
Days Sales Outstanding | 175.72 | |||||
Days Payable | 943.93 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -28.9 | |||||
Shareholder Yield % | -0.25 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 60.07 | |||||
Operating Margin % | -1100.17 | |||||
Net Margin % | -1117.97 | |||||
FCF Margin % | -941.24 | |||||
ROE % | -332.57 | |||||
ROA % | -157.66 | |||||
ROIC % | -316.21 | |||||
ROC (Joel Greenblatt) % | -5862.02 | |||||
ROCE % | -236.64 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 8.5 | |||||
PB Ratio | 8.5 | |||||
EV-to-EBIT | -2.21 | |||||
EV-to-EBITDA | -2.45 | |||||
EV-to-Revenue | 24.17 | |||||
EV-to-FCF | -1.77 | |||||
Earnings Yield (Greenblatt) % | -45.33 | |||||
FCF Yield % | -37.08 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
HeraMED Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | 0.371 | ||
EPS (TTM) (€) | -0.015 | ||
Beta | 2.18 | ||
Volatility % | 388.75 | ||
14-Day RSI | 64.25 | ||
14-Day ATR (€) | 0.001019 | ||
20-Day SMA (€) | 0.008 | ||
12-1 Month Momentum % | -74.25 | ||
52-Week Range (€) | 0.0015 - 0.04376 | ||
Shares Outstanding (Mil) | 633.25 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 4 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
HeraMED Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
HeraMED Ltd Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
HeraMED Ltd Frequently Asked Questions
What is HeraMED Ltd(STU:1I4)'s stock price today?
The current price of STU:1I4 is €0.01. The 52 week high of STU:1I4 is €0.04 and 52 week low is €0.00.
When is next earnings date of HeraMED Ltd(STU:1I4)?
The next earnings date of HeraMED Ltd(STU:1I4) is .
Does HeraMED Ltd(STU:1I4) pay dividends? If so, how much?
HeraMED Ltd(STU:1I4) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |